palmidrol has been researched along with Atrophy in 1 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Argenio, G | 1 |
| Petrosino, S | 1 |
| Gianfrani, C | 1 |
| Valenti, M | 1 |
| Scaglione, G | 1 |
| Grandone, I | 1 |
| Nigam, S | 1 |
| Sorrentini, I | 1 |
| Mazzarella, G | 1 |
| Di Marzo, V | 1 |
1 other study available for palmidrol and Atrophy
| Article | Year |
|---|---|
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Cas | 2007 |